Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 47, 4243-4247, August 15, 1987]
© 1987 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alessandri, G.
Right arrow Articles by Gullino, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alessandri, G.
Right arrow Articles by Gullino, P. M.

Influence of Gangliosides on Primary and Metastatic Neoplastic Growth in Human and Murine Cells1

Giulio Alessandri2, Stefania Filippeschi, Paola Sinibaldi, Francoise Mornet, Pietro Passera, Federico Spreafico, Pier Mario Cappa and Pietro M. Gullino

Department of Medical Sciences, University of Turin, Turin [G.A., P.M.G.]; Mario Negri Institute, Milan [S.F., F.S.], Italy; National Cancer Institute, NIH, Bethesda, MD 20892 [P.S., F.M.]; and Ospedale Maggiore San Giovanni, Turin, Italy [P.P., P.M.C.]

The influence of gangliosides on tumor growth and frequency of metastastis in vivo as well as on growth and motility of neoplastic cells in vitro was tested utilizing human and rodent cell populations. In mice receiving injections of a ganglioside mixture twice daily the tumor volume, the number of spontaneous metastases per animal, and the number of mice with metastasis was approximately double that of controls. Preincubation of neoplastic cells with the ganglioside mixture doubled the number of metastatic foci in the lungs of mice receiving the cells by i.v. injection. Addition of a ganglioside mixture to the culture medium enhanced motility of neoplastic cells about 3-fold. This finding was similar to that observed for capillary endothelium. The presence of gangliosides in the culture media for a 48-h incubation period about doubled the number of neoplastic cells as compared to controls; the same was observed for capillary endothelium. The data are interpreted to indicate that gangliosides improve growth and mobilization of capillary endothelium and neoplastic cells. Both events may concur in enhancing tumor growth in vivo, the first by improving angiogenesis, the second by direct action on the neoplastic cell population.

1 This work was supported by the Associazione Italiana Ricerca sul Cancro and Consiglio Nazionale Ricerche (Italy) P.F. Oncologia, grant 85.02058.44.

2 To whom requests for reprints should be addressed, at Dipartimento di Scienze Biomediche e Oncologia Umana, Sezione Anatomia Patologica, Via Santena 7, 10126 Torino, Italy.

Received 1/30/87. Revised 4/14/87. Accepted 4/20/87.




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
P. Mukherjee, A. C. Faber, L. M. Shelton, R. C. Baek, T. C. Chiles, and T. N. Seyfried
Thematic Review Series: Sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a
J. Lipid Res., May 1, 2008; 49(5): 929 - 938.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E.-O. Lee, H.-J. Lee, H.-S. Hwang, K.-S. Ahn, C. Chae, K.-S. Kang, J. Lu, and S.-H. Kim
Potent inhibition of Lewis lung cancer growth by heyneanol A from the roots of Vitis amurensis through apoptotic and anti-angiogenic activities
Carcinogenesis, October 1, 2006; 27(10): 2059 - 2069.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J.-E. Huh, E.-O. Lee, M.-S. Kim, K.-S. Kang, C.-H. Kim, B.-C. Cha, Y.-J. Surh, and S.-H. Kim
Penta-O-galloyl-beta-D-glucose suppresses tumor growth via inhibition of angiogenesis and stimulation of apoptosis: roles of cyclooxygenase-2 and mitogen-activated protein kinase pathways
Carcinogenesis, August 1, 2005; 26(8): 1436 - 1445.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Liu, R. Li, and S. Ladisch
Exogenous Ganglioside GD1a Enhances Epidermal Growth Factor Receptor Binding and Dimerization
J. Biol. Chem., August 27, 2004; 279(35): 36481 - 36489.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Weiss, S. Hettmer, P. Smith, and S. Ladisch
Inhibition of Melanoma Tumor Growth by a Novel Inhibitor of Glucosylceramide Synthase
Cancer Res., July 1, 2003; 63(13): 3654 - 3658.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. V. Shurin, M. R. Shurin, S. Bykovskaia, J. Shogan, M. T. Lotze, and E. M. Barksdale Jr.
Neuroblastoma-derived Gangliosides Inhibit Dendritic Cell Generation and Function
Cancer Res., January 1, 2001; 61(1): 363 - 369.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1987 by the American Association for Cancer Research.